Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee. Finks reviews exactly what concierge medicine is, as well as its role in cardio-kidney-metabolic health and her own research on compounded GLP-1 and GIP agonists in a pharmacist-managed cardiometabolic clinic. Show Notes: Finks SW, Benavides D, Martin AG, Carmon AS. Real-world observations of using compounded GLP-1 +- GIP agonists within a clinical pharmacist-managed cardiometabolic clinic. J Am Col Clin Pharm. 2024. doi:10.1002/jac5.2071 Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221-2232. doi:10.1056/NEJMoa2307563 ZupMed.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related